Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jodi M Gilman

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
JAMA Network Open|April 12, 2021
Variation in Cannabinoid Metabolites Present in the Urine of Adults Using Medical Cannabis Products in MassachusettsJodi M Gilman, William A Schmitt, Grace Wheeler, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 7, 2024
Intoxication due to Δ9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activityKeerthana Deepti Karunakaran, Michael Pascale, Nisan Ozana, et al.
Frontiers in Psychiatry|July 19, 2021
Assessing Changes in Symptoms of Depression and Anxiety During Four Weeks of Cannabis Abstinence Among AdolescentsMegan E Cooke, Jodi M Gilman, Erin Lamberth, et al.
BMJ Open|June 9, 2022
Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocolJulia Jashinski, Ellie Grossman, Aurora Quaye, et al.
JAMA Network Open|December 11, 2025
Cue-Elicited Brain Activity and Treatment Outcomes in Substance Use Disorders: A Meta-AnalysisBryn Evohr, Sean Wenzel, Nicole Chen, et al.
JAMA Network Open|September 18, 2024
Year-Long Cannabis Use for Medical Symptoms and Brain Activation During Cognitive ProcessesDebbie C L Burdinski, Alisha Kodibagkar, Kevin Potter, et al.
JAMA Pediatrics|January 29, 2024
Substance Use, Suicidal Thoughts, and Psychiatric Comorbidities Among High School StudentsBrenden Tervo-Clemmens, Jodi M Gilman, A Eden Evins, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 9, 2022
Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imagingJodi M Gilman, William A Schmitt, Kevin Potter, et al.
JAMA Network Open|January 30, 2026
Detection of Δ9-Tetrahydrocannabinol Impairment Using Resting-State Functional Near-Infrared Spectroscopy: A Randomized Clinical TrialMoshe Berchansky, A Eden Evins, Bryn Evohr, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 1, 2022
Correction to: Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imagingJodi M Gilman, William A Schmitt, Kevin Potter, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
JAMA Network Open|April 12, 2021
Variation in Cannabinoid Metabolites Present in the Urine of Adults Using Medical Cannabis Products in MassachusettsJodi M Gilman, William A Schmitt, Grace Wheeler, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 7, 2024
Intoxication due to Δ9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activityKeerthana Deepti Karunakaran, Michael Pascale, Nisan Ozana, et al.
Frontiers in Psychiatry|July 19, 2021
Assessing Changes in Symptoms of Depression and Anxiety During Four Weeks of Cannabis Abstinence Among AdolescentsMegan E Cooke, Jodi M Gilman, Erin Lamberth, et al.
BMJ Open|June 9, 2022
Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocolJulia Jashinski, Ellie Grossman, Aurora Quaye, et al.
JAMA Network Open|December 11, 2025
Cue-Elicited Brain Activity and Treatment Outcomes in Substance Use Disorders: A Meta-AnalysisBryn Evohr, Sean Wenzel, Nicole Chen, et al.
JAMA Network Open|September 18, 2024
Year-Long Cannabis Use for Medical Symptoms and Brain Activation During Cognitive ProcessesDebbie C L Burdinski, Alisha Kodibagkar, Kevin Potter, et al.
JAMA Pediatrics|January 29, 2024
Substance Use, Suicidal Thoughts, and Psychiatric Comorbidities Among High School StudentsBrenden Tervo-Clemmens, Jodi M Gilman, A Eden Evins, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 9, 2022
Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imagingJodi M Gilman, William A Schmitt, Kevin Potter, et al.
JAMA Network Open|January 30, 2026
Detection of Δ9-Tetrahydrocannabinol Impairment Using Resting-State Functional Near-Infrared Spectroscopy: A Randomized Clinical TrialMoshe Berchansky, A Eden Evins, Bryn Evohr, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 1, 2022
Correction to: Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imagingJodi M Gilman, William A Schmitt, Kevin Potter, et al.
Pageof 7